Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Konum Seçiniz
  • (212) 221 18 41 Bilgi alınız
  • (212) 221 18 41 Bilgi alınız
  • Part of brands: |
Igenomix TürkiyeIgenomix Türkiye
  • Part of brands: |
  • SİZE YOL GÖSTERİYORUZ
    • Fertilite
    • Kalıtsal hastalıkları önleyin
    • Endişesiz gebelik
  • HİZMETLERİMİZ
    • Sağlık Uzmanları için
    • Hastalar için
  • TÜM EKZOM DİZİLEME (WES) VE TANI TESTLERİ
  • HAKKIMIZDA
    • Igenomix Araştırma
    • Igenomix Hakkında
  • Webinars

Corneal Dystrophies Precision Panel

Corneal Dystrophies (CD) are a group of genetic, commonly progressive, eye disorders in which abnormal material often accumulates in the clear outer layer of the eye (the cornea). 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Corneal Dystrophies (CD) are a group of genetic, commonly progressive, eye disorders in which abnormal material often accumulates in the clear outer layer of the eye (the cornea). The onset of symptoms varies between patients, from asymptomatic from significant vision impairment cases. This condition can either affect one or both eyes, and the intensity of symptoms in that case is not necessarily equal. The age of onset and specific symptoms vary among the different forms of corneal dystrophy. CD can be grouped by which layers of the cornea is affected: Anterior/Superficial Coneal Dystrophies. 

    Stromal Corneal Dystrophies. 

    Posterior Corneal Dystrophies. 

     

  • The Igenomix Corneal Dystrophies Precision Panel can be used to make an accurate and directed diagnosis leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Corneal Dystrophies Precision Panel is indicated for those patients with a clinical diagnosis or suspicion presenting with or without the following manifestations: 
    • Dry eyes 
    • Loss of vision. 
    • Sensitivity to light 
    • Pain in the eye 
    • Corneal erosions
    • Blurred vision. 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.    
  • Early initiation of multidisciplinary treatment including a regular follow up in case of asymptomatic patients. Eye drops and ointments can be used in case of mild symptoms. Surgical treatment (corneal transplant) can be considered if the loss of vision is severe enough. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation. 

Genes & Diseases

Methodology

References

See scientific referrals

Møller, H. U., & Sunde, L. (2013). Prevalence of corneal dystrophies in the United States: estimates from claims data. Investigative ophthalmology & visual science, 54(1), 387. https://doi.org/10.1167/iovs.12-11211 

Aggarwal, S., Peck, T., Golen, J., & Karcioglu, Z. A. (2018). Macular corneal dystrophy: A review. Survey of ophthalmology, 63(5), 609–617. https://doi.org/10.1016/j.survophthal.2018.03.004 

Bourges J. L. (2017). Corneal dystrophies. Journal francais d’ophtalmologie, 40(6), e177–e192. https://doi.org/10.1016/j.jfo.2017.05.003 

Soh, Y.Q., Kocaba, V., Weiss, J.S. et al. Corneal dystrophies. Nat Rev Dis Primers 6, 46 (2020). https://doi.org/10.1038/s41572-020-0178-9 

Matthaei, M., Hribek, A., Clahsen, T., Bachmann, B., Cursiefen, C., & Jun, A. S. (2019). Fuchs Endothelial Corneal Dystrophy: Clinical, Genetic, Pathophysiologic, and Therapeutic Aspects. Annual review of vision science, 5, 151–175. https://doi.org/10.1146/annurev-vision-091718-014852 

descargar

Detaylı Açıklama

İndirin

BROŞÜR

İndirin

Request Information

SİZE YOL GÖSTERİYORUZ

Fertilite

HİZMETLERİMİZ

Genetik Çözümler
Hastalar İçin

HAKKIMIZDA

Igenomix Hakkında
Bizimle Çalışın

IGENOMIX´İ TAKİP EDİN

İletişim
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Dil Seçimi

[2024] © Igenomix Gizlilik İlkesi Kalite İlkesi Yasal Not Çerez İlkeleri     Haber ve Basın   

İletişim Formu


  • SİZE YOL GÖSTERİYORUZ
    • Fertilite
    • Kalıtsal hastalıkları önleyin
    • Endişesiz gebelik
  • HİZMETLERİMİZ
    • Sağlık Uzmanları için
    • Hastalar için
  • TÜM EKZOM DİZİLEME (WES) VE TANI TESTLERİ
  • HAKKIMIZDA
    • Igenomix Araştırma
    • Igenomix Hakkında
  • Webinars
  • Konum Seçiniz
  • Kayıtlı kullanıcılar
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT